News & Press Releases
Filter by:
Mintz advised the placement agents in the $145 million private placement of First Tracks Biotherapeutics’ common stock, which included $80 million of common stock sold by First Tracks Biotherapeutics and $65 million of common stock sold by a selling stockholder. The private placement was in connection with the spin-off of First Tracks Biotherapeutics from AnaptysBio.
TechCon Socal 2026 Announces Seven Winning Startups from the Startup Innovation Showcase Semifinal
April 22, 2026
Amit Singh participated in TechCon SoCal 2026, where Mintz hosted the Startup Innovation Showcase Semifinal in San Diego, bringing together leading founders, investors, and innovators.
Daniel Cody was quoted in a Healthcare Brew article advising physicians on how to assess whether a telemedicine company is operating legitimately before entering into a working relationship.
Latest PBM Settlement to Reverberate Through Health Plans
April 22, 2026
Member Theresa Carnegie was quoted in a Corporate Counsel article analyzing the broader impact of a recent pharmacy benefit manager (PBM) settlement and how it may affect health plans going forward.
Mintz Names Veteran Litigator to Lead New York Office
April 21, 2026
Law360 Pulse featured Francis Earley’s appointment as Managing Member of the firm’s New York office. The article highlights Frank’s extensive experience handling complex commercial and securities litigation and his leadership role overseeing one of the firm’s largest offices.
Of Counsel Michelle Capezza was quoted in a Fiduciary News article examining whether delegating investment discretion to a 3(38)-investment manager meaningfully transfers fiduciary risk or merely creates a false sense of protection for plan sponsors.
